Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CREATINE KINASE LEVELS IN WOMEN WHO CARRY GENES FOR THREE TYPES OF MUSCULAR DYSTROPHY.

Literature DB >> 14248444

CREATINE KINASE LEVELS IN WOMEN WHO CARRY GENES FOR THREE TYPES OF MUSCULAR DYSTROPHY.

K M WILSON, K A EVANS, C O CARTER.

Abstract

Entities: Species

Keywords: CREATINE KINASE; ENZYME TESTS; EXERTION; GENES; GENETICS, HUMAN; MUSCULAR DYSTROPHY; WOMEN

Mesh：

Substances：
Creatine Kinase

Year: 1965 PMID： 14248444 PMCID： PMC2166169 DOI： 10.1136/bmj.1.5437.750

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

× No keyword cloud information.

7 in total

1. Aldolase activity in the plasma or serum of normal children and families with muscular dystrophy.

Authors: B E CLAYTON; K M WILSON; C O CARTER
Journal: Arch Dis Child Date: 1963-06 Impact factor: 3.791

2. [Technique for the determination of creatine phosphokinase in blood].

Authors: J C DREYFUS; G SCHAPIRA
Journal: Rev Fr Etud Clin Biol Date: 1961 Aug-Sep

3. An investigation of the carrier state in the Duchenne type muscular dystrophy.

Authors: P LEYBURN; W H THOMSON; J N WALTON
Journal: Ann Hum Genet Date: 1961-05 Impact factor: 1.670

4. Serum enzymes and genetic carriers in muscular dystrophy.

Authors: C S CHUNG; N E MORTON; H A PETERS
Journal: Am J Hum Genet Date: 1960-03 Impact factor: 11.025

5. Muscular dystrophy in childhood; the genetic aspect; a field study in the Leeds region of clinical types and their inheritance.

Authors: H BLYTH; R J PUGH
Journal: Ann Hum Genet Date: 1959-04 Impact factor: 1.670

6. Serum enzymes in carriers of muscular dystrophy.

Authors: B P HUGHES
Journal: Br Med J Date: 1962-10-13

7. Progressive Muscular Dystrophy. V. The Identification of the Carrier State in the Duchenne Type by Serum Creatine Kinase Determination.

Authors: R Richterich; S Rosin; U Aebi; E Rossi
Journal: Am J Hum Genet Date: 1963-06 Impact factor: 11.025

7 in total

26 in total

1. The detection of carriers of benign (Becker-type) X-linked muscular dystrophy.

Authors: R Skinner; A E Emery; A J Anderson; C Foxall
Journal: J Med Genet Date: 1975-06 Impact factor: 6.318

2. Heterozygote detection in phenylketonuria. Measurement of discriminatory ability and interpretation of the phenylalanine loading test by determination of the heterozygote likelihood ratio.

Authors: A Westwood; D N Raine
Journal: J Med Genet Date: 1975-12 Impact factor: 6.318

7. [Diagnosis of female carriers of Duchenne's progressive muscular dystrophy using discriminative analysis of various serum enzyme activities].

Authors: C M Büsing; H Heyck; G Laudahn
Journal: Klin Wochenschr Date: 1969-10-15

CREATINE KINASE LEVELS IN WOMEN WHO CARRY GENES FOR THREE TYPES OF MUSCULAR DYSTROPHY.

1. Aldolase activity in the plasma or serum of normal children and families with muscular dystrophy.

2. [Technique for the determination of creatine phosphokinase in blood].

3. An investigation of the carrier state in the Duchenne type muscular dystrophy.

4. Serum enzymes and genetic carriers in muscular dystrophy.

5. Muscular dystrophy in childhood; the genetic aspect; a field study in the Leeds region of clinical types and their inheritance.

6. Serum enzymes in carriers of muscular dystrophy.

7. Progressive Muscular Dystrophy. V. The Identification of the Carrier State in the Duchenne Type by Serum Creatine Kinase Determination.

1. The detection of carriers of benign (Becker-type) X-linked muscular dystrophy.

2. Heterozygote detection in phenylketonuria. Measurement of discriminatory ability and interpretation of the phenylalanine loading test by determination of the heterozygote likelihood ratio.

3. Useful probability considerations in genetics: the goat problem with tigers and other applications of Bayes' theorem.

4. Some Biochemical Aspects of the Myopathies.

5. Genetic counselling and the physician.

6. [Creatine phosphokinase activity in serum of carriers of progressive muscular dystrophy of Duchenne type].

7. [Diagnosis of female carriers of Duchenne's progressive muscular dystrophy using discriminative analysis of various serum enzyme activities].

8. Use of creatine kinase for detecting severe X-linked muscular dystrophy carriers.

9. Quantitative electromyography in the detection of the carriers in Duchenne type muscular dystrophy.

10. Serum creatine kinase levels in pubertal, mature, pregnant, and postmenopausal women.